Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

IZUMO2 Inhibitors

IZUMO2 inhibitors are a class of chemical compounds designed to inhibit the function of the IZUMO2 protein, a crucial factor in sperm-egg fusion during fertilization. The IZUMO2 protein, belonging to the IZUMO family, is found on the surface of sperm cells and is essential for their ability to recognize and bind to the egg's membrane, facilitating fusion. Structurally, these inhibitors often feature complex molecular scaffolds that enable specific binding to the active or functional sites of the IZUMO2 protein, thereby blocking its interaction with its counterpart proteins on the oocyte. This specific binding mechanism may involve mimicking natural substrates or adopting conformations that sterically hinder protein-protein interactions. Their chemical design can range from small molecules to larger peptides, all with the goal of high selectivity and affinity for IZUMO2.

In terms of chemical diversity, IZUMO2 inhibitors vary based on their molecular backbone, functional groups, and interaction dynamics with the IZUMO2 protein surface. Many inhibitors in this class are built to exploit hydrophobic pockets or hydrogen-bonding interactions within the binding domains of IZUMO2, allowing for strong and stable inhibition. Advances in computational modeling and structure-based drug design have facilitated the identification and refinement of these inhibitors, optimizing their binding properties. The chemical properties of IZUMO2 inhibitors are usually fine-tuned to achieve specific interaction profiles, such as minimal off-target effects and optimized physicochemical properties, like solubility and bioavailability. This chemical class thus represents a significant leap in the molecular manipulation of IZUMO2, allowing for precise control over sperm-egg fusion processes through targeted protein inhibition.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

A tyrosine kinase inhibitor; IZUMO2, if phosphorylated, may be impacted by this inhibition.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

ERK pathway inhibitor; if IZUMO2 is involved in pathways influenced by ERK, its function may be affected.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor; can influence pathways that might interact with IZUMO2.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Another PI3K inhibitor that can affect pathways potentially associated with IZUMO2.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

Ca2+/calmodulin-dependent protein kinase II inhibitor; could impact any potential Ca2+ signaling involving IZUMO2.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Broad spectrum kinase inhibitor; could influence any potential kinase-related activity of IZUMO2.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

Src kinase inhibitor; if IZUMO2 has any Src kinase-related functions, they might be impacted.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor; may affect pathways that could be associated with IZUMO2.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAP kinase inhibitor; can influence any potential association of IZUMO2 with p38 MAPK signaling.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor; might influence pathways that potentially interact with IZUMO2.